{"denomUnitsSelected":"Participants","description":"CBR is defined as a partial response or better (≥PR) + minimal response (MR) rate based on International Myeloma Working Group (IMWG) criteria.","reportingStatus":"NOT_POSTED","timeFrame":"Up to 12 weeks","title":"Clinical Benefit Rate (CBR)","type":"SECONDARY"}